Previous 10 | Next 10 |
RedHill (RDHL): FY net loss of $76M.Revenue of $64.3M (+922.3% Y/Y) misses by $3.83M.Press Release For further details see: RedHill misses on revenue
RedHill Biopharma Provides Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights PR Newswire TEL AVIV, Israel and RALEIGH, N.C. , March 18, 2021 /PRNewswire/ -- Financials : Full year 2020 net revenues of approximate...
RedHill Biopharma to Host Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights Webcast on March 18, 2021 PR Newswire TEL AVIV, Israel and RALEIGH, NC , March 11, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHil...
RedHill to Present at Upcoming Conferences in March PR Newswire TEL AVIV, Israel and RALEIGH, NC , March 5, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced tha...
RedHill Biopharma Announces Closing of $35 Million Bought Deal Offering of American Depositary Shares PR Newswire TEL AVIV, Israel and RALEIGH, N.C. , March 4, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialt...
ObvioHealth and RedHill Biopharma Launch First in Kind Remote COVID-19 Therapy Trial Incorporating Highest Level of At-home Patient Monitoring to Date PR Newswire NEW YORK , March 2, 2021 /PRNewswire/ -- ObvioHealth , a global virtual research organizatio...
FibroGen (FGEN) -25% on Q4 earnings release and after FDA to hold AdCom meet to review FibroGen, AstraZeneca's kidney drug.Comstock Mining (LODE) -19% after launching 4M-share public offering.Inseego (INSG) -16% on Q4 earnings release.RedHill Biopharma (RDHL) ...
RedHill Biopharma (RDHL) announces that it has increased the size of its previously announced bought deal offering of ADSs to $35M.Shares of the company were trading down 17% premarket.The company has granted a 30-day option to the underwriter to purchase up to additional 656,2...
RedHill Biopharma Increases Previously Announced Bought Deal to $35 Million of American Depositary Shares PR Newswire TEL AVIV, Israel and RALEIGH, NC , March 2, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specia...
RedHill Biopharma (RDHL) announces that it has entered into an underwriting agreement with H.C. Wainwright under which the underwriter has agreed to purchase on a firm commitment basis 1.25M American Depositary Shares ((ADSs)) of the company, at a price of $8/ADS, with gross proceeds expected...
News, Short Squeeze, Breakout and More Instantly...
Redhill Biopharma Ltd. Company Name:
RDHL Stock Symbol:
NASDAQ Market:
Redhill Biopharma Ltd. Website:
RedHill Biopharma Strengthens Cash Balance, Settles Obligations and Removes Talicia® Lien PR Newswire TEL-AVIV, Israel and RALEIGH, NC , July 22, 2024 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biophar...
RedHill Biopharma Terminates License Agreement for Aemcolo® PR Newswire TEL-AVIV, Israel and RALEIGH, NC , July 9, 2024 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today ...
Windtree Therapeutics Inc. (WINT) is expected to report for Q1 2024 CohBar Inc. (CWBR) is expected to report for Q1 2024 hopTo Inc (HPTO) is expected to report for Q1 2024 Bitech Technologies Corporation (BTTC) is expected to report for Q1 2024 Roadzen Inc. (RDZN) is expected to r...